menopause, and estrogen use. We also report the cumulative incidences of other autoimmune diseases by sex.
Year 2 participant characteristics by incident hypothyroidism were similar in terms of BMI, diabetes duration, HbA 1c , and microvascular complications. Parity, menopausal status, and estrogen use were also similar among women. By EDIC year 18, more women than men reported incident hypothyroidism (24.6 vs. 11.3%, P , 0.0001). Cumulative incidences of other autoimmune conditions, including pernicious anemia (17 women, 4 men) and adrenal disease (2 women, 2 men), were low. Table 1 presents the risk of incident hypothyroidism associated with sex and other covariates. After multivariable adjustment, women had an increased hazard of hypothyroidism compared with men. Other covariates were not associated with increased hypothyroid risk. Among women, pregnancy, exogenous estrogen, and menopause were not associated with hypothyroidism.
To our knowledge, other studies have not examined female-specific exposures as risk factors for autoimmune disease among women with type 1 diabetes.
In the current analysis, increased estrogen exposure was not associated with increased hypothyroid risk. Increased endogenous estradiol, as in pregnancy, or increased exogenous estradiol, as with estrogen use, did not significantly increase risk beyond baseline estradiol production. Other sex-specific exposures not related to sex hormones may also explain these differences.
The strengths of the study include a large cohort, high participant retention, and 18-year follow-up. However, DCCT/ EDIC was not designed a priori to assess autoimmune disease. Self-reported disease represents clinically significant disease. However, autoantibody assays and hormone levels were not available to quantify subclinical disease, which leads to an underestimation of autoimmune disease.
In conclusion, in women with type 1 diabetes, the risk for hypothyroidism is not affected by exposure to pharmacologic estrogens, pregnancy, or menopause. Other diabetes-related factors were not associated with increased hypothyroid risk. Further research is needed to examine which exposures may increase this risk in women and whether such exposures are modifiable. Examination of sex-specific exposures and interactions with HLA types and antibody status to produce disease and how ascertainment for these diseases may differ by sex is needed.
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